New research may lead to earlier diagnosis and treatment of primary biliary cirrhosis in families

Mayo Clinic researchers have found that first-degree relatives (i.e., parents, siblings, children) of patients with primary biliary cirrhosis (PBC) are more likely to have the biomarker of the disease in their blood. Armed with this new information, physicians could screen and assess first-degree relatives of PBC patients with a simple blood test, enabling them to diagnose and treat more patients before the disease causes irreversible liver damage. These findings were published in this month’s issue of Hepatology.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news108655560.html">New research may lead to earlier diagnosis and treatment of primary biliary cirrhosis in families</a></p> <p>Mayo Clinic researchers have found that first-degree relatives (i.e., parents, siblings, children) of patients with primary biliary cirrhosis (PBC) are more likely to have the biomarker of the disease in their blood. Armed with this new information, physicians could screen and assess first-degree relatives of PBC patients with a simple blood test, enabling them to diagnose and treat more patients before the disease causes irreversible liver damage. These findings were published in this month’s issue of <i>Hepatology</i>.</p>